Import and efflux of flubendazole in Haemonchus contortus strains susceptible and resistant to anthelmintics

Veterinary Parasitology

Volumn 187, Issue 3-4, 2012, Pages 473-479

  Bártíková, Hana ^a   Vokřál, Ivan ^a   Kubíček, Vladimír ^a   Szotáková, Barbora ^a   Prchal, Lukáš ^a   Lamka, Jiří ^a   Várady, Marián ^b   Skálová, Lenka ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Drug transport; Helminths; Nematoda; Resistance; Strain differences

Indexed keywords

ANTHELMINTIC AGENT; BENZIMIDAZOLE DERIVATIVE; FLUBENDAZOLE; IVERMECTIN; VERAPAMIL;

ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DIFFUSION; DRUG RESISTANCE; DRUG SENSITIVITY; DRUG TRANSPORT; DRUG UPTAKE; EX VIVO STUDY; HAEMONCHUS CONTORTUS; LIPOPHILICITY; MULTIDRUG RESISTANCE; NONHUMAN; STRAIN DIFFERENCE;

ANIMALS; ANTHELMINTICS; DRUG INTERACTIONS; DRUG RESISTANCE; HAEMONCHUS; MEBENDAZOLE; ORGANIC ANION TRANSPORTERS; VERAPAMIL;

HAEMONCHUS CONTORTUS; NEMATODA; VERMES;

EID: 84862490930     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2012.02.008     Document Type: Article

References (32)

1. Alvarez L.I., Imperiale F.A., Sánchez S.F., Murno G.A., Lanusse C.E. Uptake of albendazole and albendazole sulphoxide by Haemonchus contortus and Fasciola hepatica in sheep. Vet. Parasitol. 2000, 94:75-89.
2. Alvarez A.I., Merino G., Molina A.J., Pulido M.M., McKellar A.Q., Prieto J.G. Role of ABC transporters in veterinary drug research and parasite resistance. Curr. Drug Deliv. 2006, 3:199-206.
3. Alvarez L.I., Mottier M.L., Lanusse C.E. Drug transfer into target helminth parasites. Trends Parasitol. 2007, 23:97-104.
4. Alvarez L.I., Mottier M.L., Sánchez S.F., Lanusse C.E. Ex vivo diffusion of albendazole and its sulphoxide metabolite into Ascaris suum and Fasciola hepatica. Parasitol. Res. 2001, 87:929-934.
5. Alvarez L.I., Sánchez S.F., Lanusse C.E. In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetics behaviour in sheep. J. Vet. Pharmacol. Ther. 1999, 22:77-86.
6. Alvarez L.I., Solana H.D., Mottier M.L., Virkel G.L., Fairweather I., Lanusse C.E. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes. Parasitology 2005, 131:501-510.
7. Bártíková H., Skálová L., Lamka J., Szotáková B., Várady M. The effects of flubendazole and its metabolites on the larval development of Haemonchus contortus (Nematode: Trichostrongylidae), an in vitro study. Helmintologia 2010, 47:269-272.
8. Bártíková H., Vokřál I., Forstová-KříŽová V., Skálová L., Lamka J., Szotáková B. The transport of albendazole and albendazole sulphoxide in the lancet fluke (Dicrocoelium dendriticum). Vet. Parasitol. 2011, 176:27-33.
9. Beugnet F., Gauthey M., Kerboeuf D. Partial in vitro reversal of benzimidazole resistance by the free-living stages of Haemonchus contortus with verapamil. Vet. Rec. 1997, 141:575-576.
10. Blackhall W.J., Prichard R.K., Beech R.N. P-glycoprotein selection in strains of Haemonchus contortus resistant to benzimidazoles. Vet. Parasitol. 2008, 152:101-107.
11. Bourguinat C., Keller K., Blagburn B., Schenker R., Geary T.G., Prichard R.K. Correlation between loss of efficacy of macrocyclic lactone heartworm anthelmintics and P-glycoprotein genotype. Vet. Parasitol. 2011, 176:374-381.
12. Dupuy J., Alvinerie M., Menez C., Lespine A. Interaction of anthelmintic drugs with P-glycoprotein in recombinant LLC-PK1-mdr1a cells. Chem. Biol. Interact. 2010, 186:280-286.
13. Geary T.G., Sangster N.C., Thompson D.P. Frontiers in anthelmintic pharmacology. Vet. Parasitol. 1999, 84:275-295.
14. James C.E., Davey M.W. Increased expression of ABC transport proteins is associated with ivermectin resistance in the model nematode Caenorhabditis elegans. Int. J. Parasitol. 2009, 39:213-220.
15. Kerboeuf D., Blackhall W., Kaminsky R., von Samson-Himmelstjerna G. P-glycoprotein in helminths: function and perspectives for anthelmintic treatment and reversal of resistance. Int. J. Antimicrob. Agents 2003, 22:332-346.
16. Kerboeuf D., Riou M. Nematodes as models for study of the regulation of activity of P-glycoproteins in multidrug resistance (MDR). Anti-infec. Agents Med. Chem. 2006, 5:389-402.
17. Lamka J., Nevole Z., Ducháček L., Velík J., Zavřel S. The comparison of mebendazole and flubendazole anthelmintic efficacy in experimental treatment of mouflon (Ovis musimon) muelleriosis. Vet. Med. Czech. 2000, 45:45-48.
18. Lamka J., Vondrejc M., Klecáková J. Effect of flubendazole on Muellerius capillaris in mouflon. Vet. Med. Czech. 2006, 41(11):347-350.
19. Lifschitz A., Entrocasso C., Alvarez L., Lloberas M., Ballent M., Manazza G., Virkel G., Borda B., Lanusse C. Interference with P-glycoprotein improves ivermectin activity against adult resistant nematodes in sheep. Vet. Parasitol. 2010, 172:291-298.
20. Lindblom T.H., Dodd A.K. Xenobiotic detoxification in the nematode Caenorhabditis elegans. J. Exp. Zool. 2006, 305A:720-729.
21. Merino G., Alvarez A.I., Prieto J.G., Kim R.B. The anthelmintic agent albendazole does not interact with p-glycoprotein. Drug Metab. Dispos. 2002, 30(4):365-369.
22. Merino G., Jonker J.W., Wagenaar E., Pulido M.M., Molina A.J., Alvarez A.I., Schinkel A.H. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2). Drug Metab. Dispos. 2005, 33(5):614-618.
23. Moreno L., Alvarez L.I., Mottier M.L., Virkel G.L., Sanches Bruni S., Lanusse C.E. Integrated pharmacological assessment of flubendazole potential for use in sheep: disposition kinetics, liver metabolism and parasite diffusion. J. Vet. Pharmacol. Therap. 2004, 27:299-308.
24. Mottier M.L., Alvarez L.I., Ceballos L., Lanusse C.E. Drug transport mechanism in helminth parasites: passive diffusion of benzimidazole anthelmintics. Exp. Parasitol. 2006, 113:49-57.
25. Mottier M.L., Alvarez L.I., Fairweather I., Lanusse C.E. Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect. J. Parasitol. 2006, 92:1355-1360.
26. Mottier M.L., Alvarez L.I., Pis M.A., Lanusse C.E. Transtegumental diffusion of benzimidazole anthelmintics into Moniezia benedeni: correlation with their octanol-water partition coefficient. Exp. Parasitol. 2003, 103:1-7.
27. Riou M., Koch C., Delaleu B., Berthon P., Kerboeuf D. Immunolocalisation of an ABC transporter, P-glycoprotein, in the eggshells and cuticles of free living and parasitic stages of Haemonchus contortus. Parasitol. Res. 2005, 96:142-148.
28. Roos M.H., Otsen M., Hoekstra R., Veenstra J.G., Lenstra J.A. Genetic analysis of inbreeding of two strains of the parasitic nematode Haemonchus contortus. Int. J. Parasitol. 2004, 34:109-115.
29. Spagnuolo P.A., Hu J., Hurren R., Wang X., Gronda M., Sukhai M.A., Di Meo A., Boss J., Ashali I., Zavareh R.B., Fine N., Simpson C.D., Sharmeen S., Rottapel R., Schimmer A.D. The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma. Blood 2010, 115(23):4824-4833.
30. Van Wyk J.A., Gerber H.M., Groeneveld H.T. A technique for recovery of nematodes from ruminants by migration from gastro-intestinal ingesta gelled in agar: large-scale application. J. Vet. Res. 1980, 47:147-158.
31. Van Wyk J.A., Van Schalkwyk P.C., Gerger H.M., Visser E.L., Alves R.M., Van Schalkwyk L. South African field strains of Haemonchus contortus resistant to the levamisole/morantel group of anthelmintics. Onderstepoort J. Vet. Res. 1989, 56(4):257-262.
32. Vokřál I., KříŽová V., Lamka J., Kubíček V., Szotáková B., Várady M., Nobilis M., Skálová L. Effect of flubendazole on biotransformation enzymes activities in Haemonchus contortus. Open Parasitol. J. 2010, 4:24-28.